Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2
slide-3

Ipf-Care Tablet

Prescription Icon
Prescription Required

Marketer

Meethi Pharmaceuticals

Salt Composition

Pirfenidone (200mg)

Overview Ipf-Care Tablet

Idiopathic pulmonary fibrosis (IPF) is treated with the prescription medication, Ipf-Care Tablets. These tablets lessen lung inflammation and scarring, improving breathing. For optimal results, take Ipf-Care Tablets with food at the same time each day. Dosage and frequency depend on individual needs and are determined by your physician to manage your symptoms effectively. Continue taking the medication as directed by your doctor. Common side effects include headache, insomnia, nausea, dizziness, diarrhea, dyspepsia, and sun sensitivity. To mitigate dizziness, avoid activities requiring alertness, such as driving. Weight loss and other side effects are possible; regular weight monitoring, or consultation with your doctor, is advised. Liver function tests may be conducted during treatment. Inform your doctor of any existing liver or kidney conditions, and all other medications you are currently using, as interactions may affect Ipf-Care's efficacy. Due to increased sun sensitivity, wear protective clothing and sunscreen outdoors. Disclose any pregnancy or breastfeeding to your physician before starting treatment.

Uses of Ipf-Care Tablet

Managing idiopathic pulmonary fibrosis

Major Benefits of Ipf-Care Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take Ipf-Care with a meal.

Common Side effects of Ipf-Care Tablet:

  • Insomnia (difficulty in sleeping)
  • Headache
  • Dizziness
  • Tiredness
  • Sinus inflammation
  • Loss of appetite
  • Upper respiratory tract infection
  • Weight loss
  • Nausea
  • Indigestion
  • Diarrhea
  • Photosensitivity

How to use Ipf-Care Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Ingest the Ipf-Care Tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication with food.

How Ipf-Care Tablet works:

Ipf-Care tablets offer antifibrotic therapy. Their mechanism involves inhibiting a specific endogenous compound implicated in the development of fibrosis. This action lessens pulmonary scarring and inflammation, thereby improving respiratory function.

SAFETY ADVICE

AlcoholAlcoholCONSULT YOUR DOCTOR

Alcohol consumption alongside Ipf-Care Tablets may pose safety risks; a physician's advice is recommended.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Ipf-Care Tablets during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to the fetus. A physician will assess the potential benefits against these risks prior to prescription. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Data on Ipf-Care Tablet use while breastfeeding is lacking. Seek medical advice from your physician.

DrivingDrivingUNSAFE

Taking Ipf-Care Tablets might reduce attentiveness, impair vision, and cause drowsiness or dizziness. Refrain from driving if you experience these effects.

KidneyKidneyCAUTION

Patients with impaired kidney function should use Ipf-Care Tablets cautiously, potentially requiring dosage modification under medical supervision. The use of Ipf-Care Tablets is contraindicated for individuals with severe kidney disease or those undergoing dialysis. A physician's consultation is advised.

LiverLiverCAUTION

Patients with liver impairment should use Ipf-Care Tablets cautiously, potentially requiring dosage modification. Consult a physician before use. Ipf-Care Tablets are contraindicated in individuals with severe hepatic dysfunction.

What if you forget to take Ipf-Care Tablet :

NA

Facts to Know About Ipf-Care Tablet

LabelValue
Chemical Category Pyridone Derivative
Developing Habits No.
Treatment Category Breathing
Action Class Pulmonary fibrosis of unknown origin

FAQs on Ipf-Care Tablet

Before starting Ipf-Care Tablet treatment, your doctor will assess your liver function. This will be monitored monthly for six months, then quarterly thereafter. Your lung function will also be periodically assessed to track your response to the medication.
Protecting your irreplaceable lung function is crucial for managing this disease. Therefore, consistently taking Ipf-Care Tablets, as directed by your doctor, is strongly advised to help maintain your current lung capacity.
Ipf-Care Tablet may cause common side effects such as sun sensitivity, nausea, fatigue, diarrhea, indigestion, appetite loss, and headache. Other reported side effects include upper respiratory and bladder infections, weight loss, insomnia, dizziness, drowsiness, altered taste, hot flashes, shortness of breath, cough, and acid reflux. Further potential side effects involve vomiting, bloating, abdominal pain, heartburn, constipation, itchy, red, dry, or rashy skin, muscle aches, joint pain, weakness, chest pain, sunburn, and elevated liver enzymes (detected via blood tests).
Ipf-Care tablets are not steroids; they're pyridines used to treat idiopathic pulmonary fibrosis (IPF) in adults. IPF causes lung tissue scarring and swelling, hindering breathing. This medication alleviates these effects, improving breathing.
You and your doctor should determine if Ipf-Care Tablet is appropriate for you. Your doctor will prescribe it only after evaluating your health. Continued use depends on your response and tolerance to the medication.
Idiopathic pulmonary fibrosis progresses unpredictably. Always consult your doctor before stopping Ipf-Care Tablet, which helps slow disease progression.
Minimize sun exposure while using Ipf-Care Tablets. Daily sunscreen use and covering exposed skin (arms, legs, and head) are recommended. Additionally, avoid smoking to maximize the tablet's effectiveness.
Pulmonary fibrosis patients typically survive 2–3 years, although some live significantly longer. Reduced survival is associated with older age, smoking, and lower BMI. Further contributing factors include advanced disease severity (radiologically and functionally) and the occurrence of additional lung complications.
Ipf-Care Tablet
302
MRP 349
13% off